Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 4/20 | 0.43 |
| ▸ | PTGDR2 | Q9Y5Y4 | 7/20 | 0.40 |
| ▸ | APEX1 | P27695 | 1/20 | 0.38 |
| ▸ | CXCR2 | P25025 | 1/20 | 0.37 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | AKR1A1 | P14550 | 3/20 | 0.34 |
| ▸ | AKR1B1 | P15121 | 3/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14602778 | 0.91 | CYP2C9 (0.44) | CYP2C9PTGDR2APEX1CXCR2HDAC6 | |
| SCHEMBL4713891 | 0.90 | CYP2C9 (0.44) | CYP2C9PTGDR2APEX1CXCR2HDAC6 | |
| SCHEMBL4715709 | 0.88 | PTGDR2 (0.45) | CYP2C9PTGDR2APEX1AKR1A1AKR1B1 | |
| SCHEMBL4761013 | 0.86 | PTGDR2 (0.52) | CYP2C9PTGDR2 | |
| SCHEMBL2803782 | 0.86 | CYP2C9 (0.54) | CYP2C9PTGDR2APEX1HDAC6HPGD | |
| SCHEMBL4713097 | 0.86 | CYP2C9 (0.43) | CYP2C9PTGDR2APEX1CXCR2AKR1A1 | |
| SCHEMBL4716936 | 0.84 | PTGDR2 (0.48) | CYP2C9PTGDR2AKR1A1AKR1B1 | |
| SCHEMBL4717537 | 0.84 | CYP2C9 (0.53) | CYP2C9PTGDR2APEX1HDAC6AKR1A1 | |
| SCHEMBL14602766 | 0.82 | CYP2C9 (0.38) | CYP2C9PTGDR2APEX1AKR1A1AKR1B1 | |
| SCHEMBL14020437 | 0.81 | CYP2C9 (0.38) | CYP2C9PTGDR2APEX1AKR1A1AKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7169924-B2 | Pyrimidinone derivatives and their use in the treatment of atherosclerosis | SMITHKLINE BEECHAM PLC (GB) | 2007-01-30 | — | — | US | disclosed |
| US-7169924-B2 | Pyrimidinone derivatives and their use in the treatment of atherosclerosis | SMITHKLINE BEECHAM PLC (GB) | 2007-01-30 | — | — | US | disclosed |